#1
|
|||
|
|||
Àêòèâíàÿ êðàïèâíèöà ( ýëüöåò èëè ýñëîòîíèí)?
Äîáðûé âå÷åð, äåâî÷êà ïîäðîñòîê 15 ëåò âåñ 55 êã ðîñò 176 , â äåòñòâå äî 7 ëåò ñòðàäàþùàÿ àòîïè÷åñêèì äåðìàòèòîì ( 8 ëåò íè÷åãî íå áûëî , êàê áóäòî ïðîøåë) .
Òðè äíÿ íàçàä ëåãêàÿ ïðîñòóäà ( çàëîæåí íîñ è ãîðëî ) è âïåðâûå ïîÿâèëàñü êðàïèâíèöà , íå ïîíÿëè îò ÷åãî, íî äóìàþ íàêîïèòåëüíîå îò íóðîôåíà . Âûïèñàëè ýëüöåò íî ÷òî òî íå ïîìîãàåò. Ïîäñêàæèòå ïîæàëóéñòà â 3 äíÿ âûïèëè ýëüöåò ( ñûïü òîëüêî àêòèâèðîâàëàñü áîëüøå ) ìîæíî ëè ñåé÷àñ ÷åðåç 7 ÷àñîâ âûïèòü Ýñëîòîíèí ? Èëè íåëüçÿ òàê ÷àñòî ? |
#2
|
||||
|
||||
à çà÷åì íóðîôåí ïðè ïðîñòóäå? ÷òî çà àêòèâíîå â-âî â îäíîì è äðóãîì ëåêàðñòâå è äîçà? ïåðåïèøèòå ñ óïàêîâîê.
ïåðåâåäèòå òåêñò íèæå íà ðóññêèé: âàø ðåáåíîê óæå âçðîñëûé - ñòàðøå 12 ëåò The recommended maximum adult dose of cetirizine and loratadine is 10 mg per day, however, European guidelines recommend non-sedating antihistamines be prescribed at up to four times the standard dose (i.e. cetirizine or loratadine 40 mg daily) before second-line medicines are considered as adjunctive treatment. Although the maximum dose is 10 mg, this medicine is often used (and required) in higher doses, without any reports of adverse effects, in order to successfully manage urticaria12,16
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#3
|
||||
|
||||
ó äåòåé ìîæåò áûòü æåëåçî-äåôèöèòíàÿ êðàïèâíèöà, îñîáåííî åñëè îíà áûñòðî âûðîñëà, îáèëüíî ìåíñòðóèðóåò è ìàëî åå êîðìèòå ìÿñîì
Oral iron therapy and chronic idiopathic urticaria: sideropenic urticaria? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#4
|
|||
|
|||
Ñïàñèáî áîëüøîå Âàäèì Âàëåðüåâè÷ ! Íà æåëåçî è ôåðèòèí ñäàäèì .
Ïèëè â 3 äíÿ ëåâîöèòåðèçèí 5 ìã íî ñûïåò äàëüøå Ñåé÷àñ õî÷ó äåçëîðàòàäèí 5 ìã ìîæíî ? Íî îáà ïüþòñÿ òèïî ðàç â ñóòêè ß ïåðåâåëà ÷òî âû ïðèñëàëè íî ó ìåíÿ äðóãèå ñîñòàâëÿþùèå ÿ íå ïîíèìàþ ( ìîæåò àíàëîãè ) Íóðîôåí äëÿ îáëåã÷åíèÿ ïðîñòóäû ( îáû÷íî ïüåì îò ãîëîâíîé áîëè |
#5
|
||||
|
||||
íåò, îàê è ôåððèòèí èëè îàê è æåëåçî, îæññ è ôåððèòèí, ëó÷øå èíâèòðî ëàáîðàòîðèÿ;
âàøè ïðåïàðàòû òðåòüåãî ïîêîëåíèÿ ñ ïðèñòàâêàìè ëåâî-Ö è äåç-Ë levocetirizine 5 mg = cetirizine 10 mg ãîëîâíûå áîëè ïðè ïðîñòóäå - òîæå ñëåäñòâèå æä, èçáûòîê ÍÏÂÑ áåç äîëæí. ãèäðàòàöèè ìîæåò ïîâðåæäàòü ïî÷êè
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#6
|
||||
|
||||
ïåðåâîäèòå òàêîå:
80 tertiary referral patients with chronic urticaria (age range, 19-67 years) were randomized for double-blind treatment with levocetirizine or desloratadine (40/40). Treatment started at the conventional daily dose of 5 mg and then increased weekly to 10 mg, 20 mg, or 20 mg of the opposite drug if relief of symptoms was incomplete. Wheal and pruritus scores, quality of life, patient discomfort, somnolence, and safety were assessed. Results 13 patients became symptom-free at 5 mg (9 levocetirizine vs 4 desloratadine), compared with 28 subjects on the higher doses of 10 mg (8/7) and 20 mg (5/1). Of the 28 patients nonresponsive to 20 mg desloratadine, 7 became symptom-free with 20 mg levocetirizine. None of the 18 levocetirizine nonresponders benefited with 20 mg desloratadine. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#7
|
||||
|
||||
ìîé êîììåíò - ÷åì âûøå äîçà äî 20 ìã (4 òàáë.) òåì ÷àøå/âûøå îòâåò íà ëå÷åíèå, ëåâîöèòåðèçèí äî 20 ìã ëó÷øå ÷åì ïåðåêëþ÷åíèå íà äåçëîðàòàäèí, íî åñëè áûëè íà ìàêñ. äåçëîðà-, òî ïåðåõîä íà ë-öåòèðèçèí 20 ñðàáàòûâàåò ó êàæäîãî 4-ãî
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
|
#8
|
|||
|
|||
Ñïàñèáî , âñå ïîíÿòíî ïî òàáëåòêàì !
Àíàëèçû ñäàäèì , òóò âûëîæó! |
#9
|
||||
|
||||
åñëè áóäóò âîïðîñû ïî àíàëèçàì - ïèøèòå, íå ñäàâàéòå èõ â áëèæàéøèå 2-3 íåäåëè; áóäåò îêàçèÿ, ïîìîãóòå äåâî÷êå ïîäñ÷èòàòü åå ïîòåðè https://forums.rusmedserv.com/showthread.php?t=29743
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#10
|
|||
|
|||
Äîáðûé äåíü,òàáëè÷êó ïî ïîòåðÿì ðàñïå÷àòàëè.( íî ñðàçó ìîãó ñêàçàòü ÷òî ïîòåðè î÷åíü áîëüøèå)
Ïî àíàëèçàì ïèøèòå íå ñäàâàòü 2-3 íåäåëè íî öåëü æå óçíàòü æåëåçîäåôèöèò( õî÷åòñÿ ïîðàíüøå óçíàòü) ,ïîýòîìó è ñäàäèì ñåé÷àñ ( íó óæå è ÎÀÊ çàîäíî,ÿ ïîíÿëà ÷òî òàì ñåé÷àñ ìîæåò âñå ñêàêàòü). Ëåâîöåòèðèçèí óâåëè÷èëè äî 2 òàáëåòîê â 12 äíÿ è â 12 íî÷è, íà äâóõ òàáëåòêàõ ëó÷øå íàìíîãî ,( ïî îêîí÷àíèþ 12 ÷àñîâ ñûïü íà÷èíàåò âûëåçàòü ) Ñêîëüêî ïî âðåìåíè ìîæíî ïèòü ïî 2 òàáëåòêè â ñóòêè? ( ÿ ïîìíþ ÷òî ìîæíî è äî ìàêñèìàëüíî 4 øò),êóðñ äíåé õî÷ó ïîíÿòü .Ñïàñèáî |
#11
|
|||
|
|||
Äîáàâëþ ïî ïîòåðÿì ñâûøå 200 ìë .
|
#12
|
||||
|
||||
Ðåáåíîê ïðèíèìàåò ïî îäíîé òàáëåòêå äâà ðàçà â äåíü? Åñëè íåò äîñòàòî÷íîãî ýôôåêòà ìû ìîæåòå äàâàòü 2 äâå óòðîì è îäíó âå÷åðîì èëè æå ïî îäíîé êàæäûå 8-9 ÷, 200 ìë ýòî î÷åíü ìíîãî äëÿ ðåáåíêà æåëåçîäåôèöèò íå âûçûâàåò ñîìíåíèé, ìîæåòå åé ïðèîáðåñòè ôåððåòàá è íà÷àòü äàâàòü ïî îäíîé â äåíü, êîãäà äîáüåòåñü ðåìèññèè êðàïèâíèöû
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#13
|
|||
|
|||
Äîáðûé âå÷åð,äâå òàáëåòêè â ñóòêè ïîëó÷àåòñÿ,õîðîøî ïîíÿëà ïðî òàáëåòêè( ÷òî ìîæíî è áîëüøå åñëè íàäî),çàâòðà áóäóò ãîòîâû àíàëèçû.
Âûõîäèò ïîêà îñòðûé ïåðèîä êðàïèâíèöû, òî è æåëåçî íåëüçÿ äàæå åñëè êðàïèâíèöà èç çà æåëåçîäåôèöèòà? Ôåððåòàá êóïèì È åùå âîïðîñ ìîæíî ëè ïîäðîñòêó òðàíåêñàì (âî âðåìÿ ýòèõ äíåé)? |
#14
|
|||
|
|||
Íó êàê âû è ãîâîðèëè ÎÀÊ ( ïðûãàþùèå ïîêàçàòåëè) îñòàëüíûå åùå íå ïðèøëè
|
#15
|
|||
|
|||
Ïî æåëåçó
|